These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 236316)

  • 1. [127-I]- or carrier-free [125-I]monoiodoinsulin.
    Sodoyez JC; Sodoyez-Goffaux F; Goff MM; Zimmerman AE; Arquilla ER
    J Biol Chem; 1975 Jun; 250(11):4268-77. PubMed ID: 236316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoiodoinsulin. Preparation, purification, and characterization of a biologically active derivative substituted predominantly on tyrosine A14.
    Hamlin JL; Arquilla ER
    J Biol Chem; 1974 Jan; 249(1):21-32. PubMed ID: 4809628
    [No Abstract]   [Full Text] [Related]  

  • 3. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
    Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
    Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes.
    Freychet P; Roth J; Neville DM
    Biochem Biophys Res Commun; 1971 Apr; 43(2):400-8. PubMed ID: 5577450
    [No Abstract]   [Full Text] [Related]  

  • 5. Chicken insulin: radioimmunological characterization and enhanced activity in rat fat cells and liver plasma membranes.
    Simon J; Freychet P; Rosselin G
    Endocrinology; 1974 Nov; 95(5):1439-49. PubMed ID: 4372041
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radioligand assay: methods and application. V. Mono-125I-insulin: preparation and immunological and biological characterization].
    Besch W; Woltanski KP; Knospe S; Ziegler M; Keilacker H
    Acta Biol Med Ger; 1980; 39(4):495-502. PubMed ID: 7004036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoiodoinsulin specifically substituted in Tyr A14 or Tyr A19.
    Linde S; Hansen B
    Int J Pept Protein Res; 1980 May; 15(5):495-502. PubMed ID: 7002822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of monoiodoinsulin.
    Linde S; Hansen B
    Int J Pept Protein Res; 1974; 6(3):157-63. PubMed ID: 4415172
    [No Abstract]   [Full Text] [Related]  

  • 9. Degradation, receptor binding affinity and biological potency of monoiodoinsulin in isolated rat fat cells.
    Gammeltoft S; Vinten J; Gliemann J; Linde S
    Horm Metab Res; 1977 May; 9(3):186-9. PubMed ID: 885469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heterogeneity of the immunoreactivity of A14, A19, B16 and B26- (125I) monoiodoinsulin to different species of anti-insulin immuno sera].
    Zhou W; Li S; Deng S
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):369-72. PubMed ID: 8150434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin.
    Misbin RI; Almira EC
    Diabetes; 1989 Feb; 38(2):152-8. PubMed ID: 2644137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triacetylated insulin: biologic activity and resistance to degradation.
    Kaplan SA; Morris JW; Davidson MB; Gerschenson LE; Scott M
    Metabolism; 1976 Nov; 25(11):1209-16. PubMed ID: 10504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of radiochemical purity and tissue binding of labelled insulin prepared by lactoperoxidase and chloramine T iodination.
    Zórad S; Svábová E; Klimes I; Macho L
    Endocrinol Exp; 1985 Dec; 19(4):267-75. PubMed ID: 3910407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
    Sonne O; Linde S; Larsen TR; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodoglucagon. Preparation and characterization.
    Desbuquois B
    Eur J Biochem; 1975 May; 53(2):569-80. PubMed ID: 1140201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like activity by fat pad assay and immunoreactive insulin. I. Their correlation in native serum acid-ethanol extract and salt-ethanol extract.
    Ide T; Kuzuya T; Kajinuma H; Kanazawa Y; Kosaka K
    Diabetes; 1969 Feb; 18(2):65-74. PubMed ID: 5763662
    [No Abstract]   [Full Text] [Related]  

  • 17. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
    Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
    J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin receptors in the liver: specific binding of ( 125 I)insulin to the plasma membrane and its relation to insulin bioactivity.
    Freychet P; Roth J; Neville DM
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1833-7. PubMed ID: 4331561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [125I]diiodoinsulins. Binding affinities, biologic potencies, and properties of their decay products.
    Pérez Maceda B; Linde S; Sonne O; Gliemann J
    Diabetes; 1982 Jul; 31(7):634-40. PubMed ID: 7160541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and biological properties of iodoinsulin labeled with one or less atoms of iodine per molecule.
    Arquilla ER; Ooms H; Mercola K
    J Clin Invest; 1968 Mar; 47(3):474-87. PubMed ID: 5637137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.